Medical Condition News

RSS

Adults with schizophrenia have increased risk of dying from suicide

Adults with schizophrenia have an elevated risk of dying from suicide. Yet there's only limited understanding of when and why people with schizophrenia die of suicide --in part because research studies have looked at relatively small groups of patients.

27 May 2021

Researchers identify new way to improve the diagnosis of fetal heart defects

UC San Francisco researchers have found a way to double doctors' accuracy in detecting the vast majority of complex fetal heart defects in utero - when interventions could either correct them or greatly improve a child's chance of survival - by combining routine ultrasound imaging with machine-learning computer tools.

27 May 2021

Neurocognitive symptoms persist 6 months post-infection with long COVID

According to the World Health Organization (WHO), COVID-19 long-haulers are people who experience symptoms such as body ache, fatigue, shortness of breath, headache, difficulty concentrating, loss of taste or smell, or other health issues long after they test negative for the virus. It can be defined as having serious and prolonged symptoms three months after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

26 May 2021

New article sheds more light on myopia control efficacy

A new paper that has been accepted for publication in Ophthalmic & Physiological Optics, the peer-reviewed journal of The College of Optometrists (UK), furthers understanding of myopia control efficacy in the context of normal childhood eye growth. Axial Length Targets for Myopia Control (Chamberlain P, et al.) is now available online via Open Access.

26 May 2021

Tsimane's brains experience less brain atrophy than Westerners as they age, indicates study

A team of international researchers has found that the Tsimane indigenous people of the Bolivian Amazon experience less brain atrophy than their American and European peers.

26 May 2021

Researchers identify structure of agent that causes Alzheimer's and Parkinson's diseases

Alzheimer's disease - also called dementia - where memory and cognitive functions gradually decline due to deformation and death of neurons, and Parkinson's disease that causes tremors in hands and arms impeding normal movement are major neurodegenerative diseases.

26 May 2021

Infrared thermal imaging camera can help monitor the progression of lymphatic filariasis

A paper published in the Journal of Clinical Medicine presents the results from a study which examined the use of an infrared thermal imaging camera as a novel non-invasive point-of-care tool for lymphatic filariasis lower-limb lymphoedema.

26 May 2021

Newly identified genetic variants play a role in bipolar disorder

Researchers from the Danish psychiatry research-project iPSYCH have contributed to identify 33 new genetic variants which, as it turns out, play a role in bipolar disorder.

26 May 2021

Prism adaptation treatment enhances functional, cognitive outcomes in people with spatial neglect

A team of experts in post-stroke neurorehabilitation confirmed that including prism adaptation treatment in standard of care for patients with post-stroke spatial neglect improved functional and cognitive outcomes according to the Functional Independence Measure®.

26 May 2021

Poor sleep impacts risk of long-term cognitive decline in Hispanic/Latino adults

Poor sleep impacts the risk of long-term cognitive decline in Hispanic/Latino middle aged and older adults differently than it does in non-Hispanic adults, according to research led by University of Miami Miller School of Medicine neurology faculty and the largest long-term study of U.S. Hispanic/Latinos to date.

26 May 2021

Postmenopausal women who underwent bilateral oophorectomy have increased risk of carpal tunnel syndrome

Carpal tunnel syndrome (CTS), which causes tingling and numbness in the hand, more commonly affects women than men and tends to peak around the age of menopause.

26 May 2021

Researchers to conduct Phase 1 gene therapy trial to treat Alzheimer's disease

The National Institute on Aging (NIA), part of the National Institutes of Health, has awarded a $5 million grant to researchers at University of California San Diego School of Medicine to conduct a first-in-human Phase 1 clinical trial of a gene therapy for treating Alzheimer's disease (AD) or Mild Cognitive Impairment (MCI), a condition that often precedes full-blown dementia.

26 May 2021

Novel compound similar to psychedelic drug can reverse effects of stress in mice

A novel compound similar in structure to the psychedelic drug ibogaine, but lacking its toxic and hallucinogenic effects, has been found to rapidly reverse the effects of stress in mice.

26 May 2021

Researchers synthesize potential drugs with anti-cancer effects

New effective compounds, which can be endogenous donors of a signaling molecule - hydrogen sulfide in the body, were synthesized by SUSU scientists. Due to this property, the obtained compounds are potential drugs with a cancer-preventing effect.

26 May 2021

Altered blood flow in the brain may cause symptoms of Parkinson's disease

Patients who suffer from REM sleep behavior disorder have altered blood flow in the brain, which can lead to a lack of oxygen in the brain tissue. In the long term, this may cause symptoms of Parkinson's disease. This is shown by research from Aarhus University and Aarhus University Hospital.

26 May 2021

Enrolment in high-deductible health plan may not be linked to asthma exacerbations

How does the switch to a high-deductible health plan affect children with asthma? A new study led by researchers at the Harvard Pilgrim Health Care Institute suggests that enrollment in a high-deductible health plan (HDHP) may not be associated with changes in asthma medication use or asthma exacerbations when medications are exempt from the deductible.

26 May 2021

Researchers identify mechanism that may lead to new therapies for strokes, brain injuries

In a surprising discovery, researchers at Massachusetts General Hospital (MGH) identified a mechanism that protects the brain from the effects of hypoxia, a potentially lethal deprivation of oxygen.

26 May 2021

Vaccination program reduces HPV-related diseases in gay, bisexual men

A study by Monash University and Alfred Health found a 70 per cent reduction in one type of human papillomavirus (HPV) in gay and bisexual men after the implementation of the school-based HPV vaccination program.

26 May 2021

Scientists propose new strategies to find drugs that neutralize critical enzymes

Scientists from the University of Bath explore racemases and propose strategies for finding drugs that target these important enzymes.

26 May 2021

Kennedy Krieger Institute researcher wins NIH award for movement learning study

The National Institutes of Health (NIH) recently awarded Amy Bastian, Ph.D., PT, chief science officer and director of the Motion Analysis Lab at Kennedy Krieger Institute, with an eight-year, $4.7 million National Institute of Neurological Disorders and Stroke (NINDS) Research Program Award (N35) to support a study examining movement learning mechanisms and how this process is affected by brain damage.

26 May 2021

Medical Condition News

Adults with schizophrenia have increased risk of dying from suicide

Researchers identify new way to improve the diagnosis of fetal heart defects

Neurocognitive symptoms persist 6 months post-infection with long COVID

New article sheds more light on myopia control efficacy

Tsimane's brains experience less brain atrophy than Westerners as they age, indicates study

Researchers identify structure of agent that causes Alzheimer's and Parkinson's diseases

Infrared thermal imaging camera can help monitor the progression of lymphatic filariasis

Newly identified genetic variants play a role in bipolar disorder

Prism adaptation treatment enhances functional, cognitive outcomes in people with spatial neglect

Poor sleep impacts risk of long-term cognitive decline in Hispanic/Latino adults

Postmenopausal women who underwent bilateral oophorectomy have increased risk of carpal tunnel syndrome

Researchers to conduct Phase 1 gene therapy trial to treat Alzheimer's disease

Novel compound similar to psychedelic drug can reverse effects of stress in mice

Researchers synthesize potential drugs with anti-cancer effects

Altered blood flow in the brain may cause symptoms of Parkinson's disease

Enrolment in high-deductible health plan may not be linked to asthma exacerbations

Researchers identify mechanism that may lead to new therapies for strokes, brain injuries

Vaccination program reduces HPV-related diseases in gay, bisexual men

Scientists propose new strategies to find drugs that neutralize critical enzymes

Kennedy Krieger Institute researcher wins NIH award for movement learning study

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News